Titre :
  • Adjuvant lapatinib for women with early-stage HER2-positive breast cancer: A randomised, controlled, phase 3 trial
Auteur : Goss, Paul E ; Smith, Ian ; O'Shaughnessy, Joyce ; Ejlertsen, Bent ; Kaufmann, Manfred ; Boyle, Frances F. ; Buzdar, Aman ; Fumoleau, Pierre P. ; Gradishar, William W. ; Martin, Miguel ; Moy, Beverly B. ; Piccart-Gebhart, Martine ; Pritchard, Kathleen ; Lindquist, Deborah D. ; Chavarri-Guerra, Yanin Y. ; Aktan, Gursel ; Rappold, Erica E. ; Williams, Lisa L.S. ; Finkelstein, Dianne D.M.
Informations sur la publication : Lancet oncology, 14, 1, (page 88-96)
Statut de publication : Publié, 2013-01
Sujet CREF : Cancérologie
Mots-clés MeSH : Adult
Aged
Aged, 80 and over
Antibodies, Monoclonal, Humanized -- administration & dosage
Breast Neoplasms -- drug therapy -- pathology
Chemotherapy, Adjuvant -- adverse effects
Disease-Free Survival
Drug-Related Side Effects and Adverse Reactions -- chemically induced -- classification
Female
Humans
Lymph Nodes -- pathology
Middle Aged
Neoplasm Staging
Quinazolines -- administration & dosage -- adverse effects
Receptor, ErbB-2 -- metabolism
Note : SCOPUS: ar.j
Langue :
  • Anglais
Identificateurs : urn:issn:1470-2045 
info:doi/10.1016/S1470-2045(12)70508-9
info:pii/S1470204512705089
info:pmid/23234763